According to an ESPN report, Mets outfield prospect Cesar Puello, 21, has been linked to performance enhancing drug provider Anthony Bosch and his Biogenesis clinic. Along with Puello, there are four other players named in the new report, including former Mets prospect Fernando Martinez. Toby Hyde of Mets Minor League Blog ranked Puello as the Mets’ sixth best prospect coming into 2012. Puello’s stock has dipped, but he’s still viewed by most observers as a top 20 prospect in the organization.
The ESPN report said that the players named were on a list of those who had received performance enhancing drugs from the Florida based clinic, but noted that the list wasn’t concrete proof of their guilt.
Earlier this winter, Bosch and Biogenesis were put on the map after Alex Rodriguez, Ryan Braun, Melky Cabrera, Francisco Cervelli, and others were named in records indicating they had received performance enhancing drugs from the clinic.
Puello, who is currently on the 40 man roster, finished up last season with high A St. Lucie (where he missed time with a broken bone in his hand). It was expected that he’d open 2013 in AA Binghamton.
Here’s the statement from the Mets on Puello, per the beat writers on Twitter:
Because of the ongoing investigation, we have no comment. We refer all questions to Major League Baseball.
It’s unclear at this point what impact Puello’s inclusion on the Biogenesis list will have on his future with the team.